Announcements Trials

Browse Landscape

Status

Unknown 14 Recruiting 8 Completed 6 Active not recruiting 2 Withdrawn 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Pancreatic Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Cancer 1 Laryngeal Neoplasms 1 Laryngeal Diseases 1 Inoperable œsophageal Cancer 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Adenocarcinoma Of Esophagus 1

Interventions

Capecitabine 35 Oxaliplatin 32 Fluorouracil 29 Leucovorin 26 Irinotecan 22 Bevacizumab 19 Cetuximab 17 Radiotherapy 16 Radiation 11 Surgical Procedures, Operative 6 Radiotherapy, Intensity-Modulated 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 Celecoxib 5 Neoadjuvant Therapy 4 Immunohistochemistry 4 Biopsy 4 Amplified Fragment Length Polymorphism Analysis 4 cediranib 3 Reverse Transcriptase Polymerase Chain Reaction 3 Receptor Protein-Tyrosine Kinases 3 Folfox protocol 3 Drug Therapy 3 Cisplatin 3 sargramostim 2 regorafenib 2 pembrolizumab 2 fludarabine phosphate 2 aldesleukin 2 Surveys and Questionnaires 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Rectal Neoplasms × Chemoradiotherapy × Clear all

NCT02233595 2019-08-13

Rectal PET/MRI

University of California, San Francisco

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡